Clinical outcome of leiomyosarcomas of vascular origin: Comparison with leiomyosarcomas of other origin

Annals of Oncology

Volumn 21, Issue 9, 2010, Pages 1915-1921

  Italiano, A ^a   Toulmonde, M ^a   Stoeckle, E ^a   Kind, M ^a   Kantor, G ^a   Coindre, J M ^a   Bui, B ^a  

^a INSTITUT BERGONIÉ   (France)

Author keywords

Chemotherapy; Leiomyosarcoma of vascular origin

Indexed keywords

ANTHRACYCLINE DERIVATIVE; ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; DACARBAZINE; DOCETAXEL; DOXORUBICIN; ETOPOSIDE; GEMCITABINE; IFOSFAMIDE;

ADULT; ARTICLE; BRACHYTHERAPY; CANCER GRADING; CANCER SURVIVAL; CONTROLLED STUDY; DRUG RESPONSE; EXTERNAL BEAM RADIOTHERAPY; FEMALE; FEMORAL VEIN; HUMAN; ILIAC ARTERY; INFERIOR CAVA VEIN; LEIOMYOSARCOMA; MAJOR CLINICAL STUDY; MALE; METASTASIS; OVERALL SURVIVAL; POPLITEAL VEIN; PRIORITY JOURNAL; PROGNOSIS; SAPHENOUS VEIN; SUPERFICIAL FEMORAL ARTERY; TREATMENT OUTCOME; VASCULAR SURGERY;

AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COHORT STUDIES; COMBINED MODALITY THERAPY; FEMALE; HUMANS; LEIOMYOSARCOMA; LIVER NEOPLASMS; LUNG NEOPLASMS; MALE; MIDDLE AGED; RADIOTHERAPY DOSAGE; SURVIVAL RATE; TREATMENT OUTCOME; VASCULAR NEOPLASMS;

EID: 77956116866     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdq039     Document Type: Article

References (18)

1. Enzinger F, Weiss S. Soft Tissue Tumors. St Louis: Mosby 2007.
2. Kevorkian J, Cento DP. Leiomyosarcoma of large arteries and veins. Surgery 1973; 73: 390-400.
3. Stringer BD. Leiomyosarcoma of artery and vein. Am J Surg 1977; 134: 90-94.
4. Dzsinich C, Gloviczki P, van Heerden JA et al. Primary venous leiomyosarcoma: a rare but lethal disease. J Vasc Surg 1992; 15: 595-603.
5. Sakpal SV, Mehta R, Babel N, Chamberlain RS. Peripheral artery leiomyosarcoma. J Vasc Surg 2009; 49: 217-221.
6. Mingoli A, Cavallaro A, Sapienza P et al. International registry of inferior vena cava leiomyosarcoma: analysis of a world series on 218 patients. Anticancer Res. 1996; 16: 3201-3205.
7. Fletcher C, Unni K, Mertens F (eds). World Health Organization Classification of Tumours Pathology and Genetics of Tumours of Soft Tissue and Bone. 2002; IARC Press, Lyon.
8. Trojani M, Contesso G, Coindre JM et al. Soft-tissue sarcomas of adults; study of pathological prognostic variables and definition of a histopathological grading system. Int J Cancer 1984; 33: 37-42.
9. Guillou L, Coindre JM, Bonichon F et al. Comparative study of the National Cancer Institute and French Federation of Cancer Centers Sarcoma Group grading systems in a population of 410 adult patients with soft tissue sarcoma. J Clin Oncol 1997; 15: 350-362.
10. World Health Organization. International Classification of Diseases, 1965 Revision. Geneva, Switzerland: World Health Organization 1967.
11. Therasse P, Arbuck SG, Eisenhauer EA et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 2000; 92: 205-216.
12. Hines OJ, Nelson S, Quinones-Baldrich WJ, Eilber FR. Leiomyosarcoma of the inferior vena cava: prognosis and comparison with leiomyosarcoma of other anatomic sites. Cancer 1999; 85: 1077-1083.
13. Hirota S, Isozaki K, Moriyama Y et al. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science 1998; 279: 577-580.
14. Miettinen M, Lasota J. Gastrointestinal stromal tumors-definition, clinical, histological, immunohistochemical, and molecular genetic features and differential diagnosis. Virchows Arch. 2001; 438: 1-12.
15. Ito H, Hornick JL, Bertagnolli MM et al. Leiomyosarcoma of the inferior vena cava: survival after aggressive management. Ann Surg Oncol 2007; 14: 3534-3541.
16. Van Glabbeke M, van Oosterom AT, Oosterhuis JW et al. Prognostic factors for the outcome of chemotherapy in advanced soft tissue sarcoma: an analysis of 2,185 patients treated with anthracycline-containing first-line regimens-a European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Study. J Clin Oncol 1999; 17: 150-157.
17. Penel N, Italiano A, Isambert N et al. Factors affecting the outcome of patients with metastatic leiomyosarcoma treated with doxorubicin-containing chemotherapy. Ann Oncol. 2009 Oct 30. [Epub ahead of print] doi:10.1093/annonc/mdp485.
18. Penel N, Taieb S, Ceugnart L et al. Report of eight recent cases of locally advanced primary pulmonary artery sarcomas: failure of Doxorubicin-based chemotherapy. J Thorac Oncol 2008; 3: 907-911.